Attia accepted into Institut Pasteur program in Infectious Diseases
Options Lab receives CIHR funding for grant entitled “The Future of PrEP Is Now”
Options Lab Manager Attia Qamar has been accepted into the Online Diploma of Infectious Diseases program at the prestigious Institut Pasteur in Paris, France. She will be completing her studies part-time, remotely, while continuing her work with our team. Félicitations Attia!
Options Lab PDF Oscar Pico-Espinosa receives award
In collaboration with the Community-Based Research Centre, we received a $300000 CAD grant to conduct formative research on planning for long-acting PrEP options in Canada. Read more about the funded grants in this competition here.
Options Lab MSc student Robinson Truong awarded his third scholarship!
Oscar’s research on Reasons for declining PrEP, part of the PRIMP project, received a Trainee Award and will be presented at the major infectious diseases conference ID Week at the end of September 2021. Congratulations Oscar! See the conference webpage here.
Darrell presents at National HIV youth leadership conference
Robinson Truong has been awarded the Li Ka Shing Excellence Award! You can read more about the award here.
Darrell awarded a Tier 2 Canada Research Chair in HIV Prevention and STI Research
You can read more about it here!
Options Lab receives federal funding for COVID-19 prevention trial, ranking 2nd out of 438 in competition
Darrell has been appointed a Tier 2 Canada Research Chair in HIV Prevention and STI Research. More information can be found here.
Darrell elected to the Governing Council of the International AIDS Society
As of June 25, 2020, the Options Lab received federal funding for a COVID-19 clinical trial which aims to investigate if a 14 day course of oral Kaletra (lopinavir/ritonavir), which is currently used as one strategy for HIV post-exposure prophylaxis (PEP), is effective as COVID-19 PEP. More information can be found here.
CATIE Interview: Darrell Talks PrEP and nPEP Guidelines
As of June 8, 2020, Darrell has been elected to the Governing Council of the International AIDS Society (IAS). You can read more about this here.
Globe and Mail: Higher-risk groups should get greater access to HIV drugs, new guidelines say
Darrell sat down with the folks at CATIE to discuss PrEP and the publication of Canada’s first PrEP and nPEP Guidelines in CMAJ.
Darrell spoke with the Globe and Mail about the PrEP and nPEP guidelines and the importance of educating more providers about PrEP to support scale-up. “Because PrEP is so effective in treating HIV, the goal is that by increasing uptake, we could actually move Canada towards a reduction in the rate of HIV infections every […]